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DOES
HYPERCHOLESTEROLEMIA
IMPROVE OPERATIVE
OUTCOMES IN PATIENTS
WITHOUT CORONARY
ARTERY DISEASE WHO
UNDERGO CARDIAC
SURGERY?
To the Editor:
Tabata and colleagues1 found that
preoperative use of statins was associ-
ated with lower operative mortality in
patients without coronary artery dis-
ease who underwent cardiac valve sur-
gery and suggested that the pleiotropic
effects of statins may be an important
biological mechanism underlying this
beneficial effect.
Although the authors did not include
preoperative serum cholesterol levels
in the analysis because they were not
measured in all patients, they specu-
lated that a beneficial effect of a de-
creased serum cholesterol might not
be ruled out.1 However, the study
suggests that higher baseline choles-
terol levels might actually improve
operative outcomes in patients without
coronary artery disease who undergo
cardiac surgery. In fact, baseline total
cholesterol levels of statin-treated pop-
ulations are higher than those of the
general population.2
Critical care literature provides
strong evidence for a survival advan-
tage associated with higher lipid
levels in critically ill surgical patients.3
Furthermore, in surgical patients,
hypocholesterolemia, beyond being
a strong predictor of in-hospital death,
also predicts nosocomial infections
and length of hospital stay.4 In particu-
lar, it has been shown that critically low
cholesterol concentrations in patients
after cardiothoracic surgery are associ-
ated with a significantly increased risk
for mortal outcome.5
Therefore, we suggest that in indi-
viduals studied by Tabata and col-
leagues,1 statin use selected the
healthy statin user or unselected the
unhealthy patients with low choles-
terol.
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We appreciate the comments from
Mascitelli and colleagues. We have
shown that preoperative statin use is as-
sociated with lower operative mortality
in cardiac surgical patients without coro-
nary artery disease.1 As they pointed out
and as we described in the original arti-
cle,1 serum cholesterol level could be
a potentially confounding factor of the
association between preoperative statin
use and operative outcomes. However,
the effect of baseline hypocholesterole-
mia on operative outcomes in patients
having cardiac surgery remains un-
known. The previous studies, including
ones that Mascitelli and colleagues refer-
enced, did not reveal an effect. In another
study, Horwich and colleagues2 have
shown that lower serum cholesterol level
at the time of admission is associated
with increased mortality in patients
with heart failure, and that patients with
lower serum cholesterol levels were
more likely to be on lipid-lowering med-
ication. Although the study population
of this study is not patients having sur-
gery, their findings indicate that serum
cholesterol level may be a negative con-
founding factor in our analysis, which
would not affect our conclusion. Further
investigation is necessary to determine
the effect of preoperative statins on oper-
ative outcomes in cardiac surgery.
Minoru Tabata, MD, MPH
Tokyo, Japan
that enable the cells to acclimatize
and survive in low oxygen conditions.
Although a low-level presence of
HIF-1a has been reported in the cyto-
plasmic compartment of cells grown
under normoxia, hypoxia stabilizes
HIF-1a against degradation and pro-
motes its translocation to the nucleus,
where it forms functional complexes
for gain of functions. As a part of our
the effect of IP can be duplicated by
manipulation of the cells for hypoxia-
related miRNAs to promote donor
cell survival.
Khawaja Husnain Haider, MPharm,
PhD
Ha Won Kim, PhD
Muhammad Ashraf, PhD
Department of Pathology and
Laboratory Medicine
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FACTOR-1a IN STEM CELL
PRECONDITIONING:
MECHANISTIC ROLE OF
HYPOXIA-RELATED MICRO-
RNAS
To the Editor:
Since its inception more than 2 de-
cades ago, ischemic preconditioning
(IP) is considered as the most powerful
cytoprotective stimulus and is being
devised as a potent strategy to promote
stem cell survival post-engraftment in
the infarcted heart.1 The elegant study
from Hu and colleagues2 is a step for-
ward toward the use of low oxygen cul-
ture conditions to trigger activation of
survival signaling pathways in the cells
before their engraftment in vivo. The
authors showed significantly improved
survival of the hypoxia-treated (0.5%
oxygen for 24 hours) mesenchymal
stem cells after engraftment in the in-
farcted heart. Unlike many of the previ-
ous studies, an important aspect of the
study protocol was cell engraftment
during the acute phase of myocardial
infarction to assess the effectiveness
of a preconditioning approach. Acute
phase engraftment exposed the en-
grafted cells to the harsh, cytokine-
rich microenvironment of the infarcted
myocardium, which was aggravated
even more because of the infiltration
of inflammatory and progenitor cells
as a part of the intrinsic repair
process. The authors attributed the
effectiveness of the hypoxic precondi-
tioning approach to up-regulation of
hypoxia inducible factor (HIF)-1a, a
heterodimeric master switch of a
hypoxia-responsive array of genes
continuing endeavor to precondition
donor cells for their better survival in
the infarcted heart and that too with
clinical relevance,3 we share our expe-
rience of extrapolating the classic IP
strategy of exposing the cells to multi-
ple sublethal ischemia/reoxygenation
cycles of short duration to promote
mesenchymal stem cell survival
(unpublished data). This approach rep-
resents an extension of the one-time,
long-term exposure to sublethal
hypoxia approach suggested by Hu
and colleagues.2 Our results showed
significant up-regulation of HIF-1a in
an Akt-dependent manner in the cells
preconditioned by 2 cycles of ische-
mia-reperfusion of 30 minutes each.
These molecular events successfully
attenuated donor cell attrition on subse-
quent exposure to lethal ischemic
insult. The participation of hypoxia-
associated micro RNAs (miR), miR-
107 and miR-210,4 downstream of
HIF-1a in translation of cytoprotective
effects of IP was another important
observation in our study. HIF-1a–
specific RNA interference abrogated
both miR-107 and miR-210 in the
preconditioned cells transfected with
HIF-1a–specific siRNA with a con-
comitant increase in preponderance of
apoptotic cells. Our in vivo experimen-
tal results in a rodent model of acute
myocardial infarction showed that
transplanted preconditioned cells sur-
vived significantly better compared
with their nonpreconditioned counter-
parts. Moreover, transplantation of
preconditioned cells promoted miR-
107 and -210 expression in the in-
farcted heart at the site of the cell graft.
These novel findings necessitate more
in-depth studies to elucidate whether
University of Cincinnati Medical
Center
Cincinnati, Ohio
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THE IMPLICATIONS OF
OUTCOME PREDICTORS
WHEN TRANSITIONING FROM
ARTERIALTO DOUBLE-
SWITCH SURGERY
To the Editor:
I read with great interest the fate of
the systemic ventricle after double-
switch surgery among those who had
left ventricle (LV) training.1 The
authors concluded that LV training
with pulmonary artery (PA) banding
resulted in a worse outcome after the
double-switch procedure. I would like
to add a few potential explanations
for their findings. One of the impor
tant aspects of the decline in function
can be related to the coronary circula-
tion and its aberrant network in
patients with corrected transposition
of the great arteries.2 This has been
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